Earnings Scheduled For December 15, 2022
Companies Reporting Before The Bell
• Trinity Biotech (NASDAQ:TRIB) is expected to report quarterly loss at $0.04 per share on revenue of $19.50 million.
ImmunoPrecise Antibodies Ltd. Announces Voluntary Delisting From TSX Venture Exchange
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ:IPA) (TSXV:IPA) announces that it has applied and has received approval for a voluntary delisting of its common shares from the
ImmunoPrecise Antibodies Q1 Sales $4.70M Beat $4.02M Estimate
ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly sales of $4.70 million which beat the analyst consensus estimate of $4.02 million by 16.92 percent. This is a 25.87 percent increase over sales of $3.73 million
The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For March 16, 2022
Companies Reporting Before The Bell
• Ideanomics (NASDAQ:IDEX) is likely to report quarterly loss at $0.05 per share on revenue of $33.20 million.
Immunoprecise, Elektrofi To Pursue Low-Volume Injectable Formulation Of IPA’s COVID-19 Antibody Cocktail
Elektrofi and Immunoprecise Antibodies Ltd (NASDAQ:IPA) have collaborated to explore a high-concentration formulation of IPA’s COVID-19 antibody cocktail, PolyTope TATX-03. The collaboration aims…
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb’s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 198 companies made new 52-week lows.
